Tacrus (Page 2 of 2)

Overdosage

If you accidentaly swallow some ointment

If you accidentally swallow the ointment, consult your doctor or pharmacist as soon as possible. Do not try to induce Vomiting.

If you forget to use Tacrus ^®

If you forget to apply the ointment at the scheduled time, do it as soon as you remember and then continue as before. If you have any further questions on the use of this product, ask your doctor or pharmacist.

How supplied

10 g packs.

30 g packs.

Storage

Do not store above 25 °C.

Keep out of the reach and sight of children.

^® after the expiry date which is stated on the tube and carton after Exp. The expiry date refers to the last day of that month.

THIS IS A MEDICAMENT

• Medicament is a product which affects your health and its consumption contrary to instructions is dangerous for you.
• Strictly follow the doctor’s prescription, the method of use and the instruction of the pharmacist who sold the medicament.
• The doctor and the pharmacist are experts in medicine, its benefits and risks.
• Do not by yourself interrupt the period of treatment prescribed for you.
• Do not repeat the same prescription without consulting your doctor.
• Keep medicament out of reach of children.

Secondary Package 10 g

Secondary Package 30 g

Primary Package 30 g

Primary Package 10 g

TACRUS tacrolimus ointment

Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:82160-124 Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TACROLIMUS (TACROLIMUS ANHYDROUS) TACROLIMUS ANHYDROUS 30 mg in 30 g

Product Characteristics Color white Score Shape Size Flavor Imprint Code Contains

Packaging # Item Code Package Description Multilevel Packaging 1 NDC:82160-124-01 1 TUBE in 1 CARTON contains a TUBE 1 30 g in 1 TUBE This package is contained within the CARTON (82160-124-01) 2 NDC:82160-124-02 1 TUBE in 1 CARTON contains a TUBE 2 10 g in 1 TUBE This package is contained within the CARTON (82160-124-02)

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 12/11/2014

Labeler — Pella Pharmaceuticals Co. Ltd (562370925)

Revised: 01/2023 Pella Pharmaceuticals Co. Ltd